Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Angelin

Showing results (121-130 of 262) with videos related to

Pageof 27
Sort By:
Journal of Internal Medicine|February 2, 2017
Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-IIIM Ghosh Laskar, M Eriksson, M Rudling, et al.
European Journal of Clinical Investigation|June 1, 1988
Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microfloraA Arvidsson, B Leijd, C E Nord, et al.
Clinical Chemistry|October 1, 1993
Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrationsG Eggertsen, R Tegelman, S Ericsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1997
No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemiaA Bröijersén, M Eriksson, B Leijd, et al.
Clinical Science and Molecular Medicine|September 1, 1977
Influence of deoxycholic acid on biliary lipids in manJ Ahlberg, B Angelin, K Einarsson, et al.
Journal of Lipid Research|November 1, 1978
Influence of cholestyramine on synthesis of cholesterol and bile acids in germfree ratsB E Gustafsson, B Angelin, K Einarsson, et al.
Circulation|August 10, 1999
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humansM Eriksson, L A Carlson, T A Miettinen, et al.
Biological Psychiatry|August 15, 1996
Cholesterol lowering and cerebrospinal fluid neurotransmitters: increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteersM Eriksson, T Eklundh, S Sjöberg, et al.
The American Journal of Pathology|December 10, 1998
Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradationM Rudling, M Gåfvels, P Parini, et al.
Lakartidningen|February 23, 1994
[Analysis of apolipoproteins in clinical diagnosis. Standardization increases the diagnostic value]L Berglund, B Angelin, G Eggertsen, et al.
Pageof 27

Showing results (121-130 of 262) with videos related to

Sort By:
Pageof 27
Journal of Internal Medicine|February 2, 2017
Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-IIIM Ghosh Laskar, M Eriksson, M Rudling, et al.
European Journal of Clinical Investigation|June 1, 1988
Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microfloraA Arvidsson, B Leijd, C E Nord, et al.
Clinical Chemistry|October 1, 1993
Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrationsG Eggertsen, R Tegelman, S Ericsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1997
No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemiaA Bröijersén, M Eriksson, B Leijd, et al.
Clinical Science and Molecular Medicine|September 1, 1977
Influence of deoxycholic acid on biliary lipids in manJ Ahlberg, B Angelin, K Einarsson, et al.
Journal of Lipid Research|November 1, 1978
Influence of cholestyramine on synthesis of cholesterol and bile acids in germfree ratsB E Gustafsson, B Angelin, K Einarsson, et al.
Circulation|August 10, 1999
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humansM Eriksson, L A Carlson, T A Miettinen, et al.
Biological Psychiatry|August 15, 1996
Cholesterol lowering and cerebrospinal fluid neurotransmitters: increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteersM Eriksson, T Eklundh, S Sjöberg, et al.
The American Journal of Pathology|December 10, 1998
Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradationM Rudling, M Gåfvels, P Parini, et al.
Lakartidningen|February 23, 1994
[Analysis of apolipoproteins in clinical diagnosis. Standardization increases the diagnostic value]L Berglund, B Angelin, G Eggertsen, et al.
Pageof 27